Serotransferrin, talin-1, alpha-2HS glycoprotein, and transthyretin (TTR) were found to have lower level, whereas fibrinogen-α chain was found to have higher level in CAD plasma compared to healthy control. TTR may consider to serve as a tool for CAD screening and therapeutic target. This evidence concerns the gene TTR and coronary artery disorder.